• Avantect Ovarian Cancer Test
  • Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)
  • Vitamin K1
  • Legionella pneumophilia antigen, DFA
  • DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
  • Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
  • Babesia microti Antibody, IgM, IFA
  • Williams Syndrome, 7q11.23 Deletion, FISH, Blood
  • Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
  • MDM2 Gene Amplification, FISH
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Reference Ranges
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...